180 likes | 347 Views
Today's Objectives. CFC's as environmental issue: Montreal ProtocolFDA's Phase out process for CFC inhalersImportance of pharmacist as information source for patients during conversionAsthma and COPD: Prevalence, treatment guidelines, inhalers in treatmentWhat's different between CFC and HFA inhalers?Steps for patients in converting to HFA formulations: dosing and costPharmacists role in providing patients with information and steps to do so.
E N D